baber/WOPTO huggingface dataset:
Patent JP-4195156-B2 (JP)
IPC: G06K19/00
Filed: 1999-09-17
Granted: 2008-12-10
Abstract: The chip card has a communication mode recognition device (7) that recognizes communication mode of a terminal in which it is inserted. A device is provided for connecting memory (6) to the communication mode recognition device (7) for selection of parameters. A parameter set delivery device (11) delivers a parameter set to gain access to an application server. Independent claims are made for a communications terminal, a communications system and a communications procedure for use with the chip card.
Patent JP-H0688708-B2 (JP)
IPC: B65H23/24
Filed: 1989-10-12
Abstract: A spreader bar apparatus (10A) is disclosed for separating slit portions (30-34) of a web (WA). The apparatus includes a first spreader bar (12A) which extends in a cross-machine direction (CD) relative to the web. The first spreader bar (12A) is bowed relative to the slit portions (30-34) such that the slit portions are separated axially relative to each other when the slit portions (30-34) are guided around the first spreader bar (12A). A second spreader bar (14A) is disposed downstream relative to the first bar (12A) and extends in a cross-machine direction (CD) relative to the web (WA) for guiding the separated slit portions (40-44). The second bar (14A) is bowed relative to the separated slit portions (40-44) such that each of the slit portions (50-54) disposed downstream relative to the second bar (14A) is disposed parallel to each other. A first and a second porous layer are connected to the first and second bars (12A, 14A) respectively such that when the bars are connected to a source of pressurized air, air flows through the bars (12A, 14A) and the porous layers towards the slit portions(30-34, 40-44) for generating respectively a first and second air cushion. The cushions reduce the frictional resistance between the moving slit portions (30-34, 40-44) and the bars (12A, 14A). Additionally, the air cushions reduce the noise level caused by movement of the slit portions when the slit portions move relative to and are guided by the spreader bars (12A, 14A).
Patent JP-4015329-B2 (JP)
IPC: H01J37/20
Filed: 1999-09-20
Granted: 2007-11-28
Abstract: A room ionization system includes a plurality of emitter modules, each including an electrical ionizer. The emitter modules are spaced around the room and are connected in a daisy-chain manner to a system controller. Each emitter module has an individual address for allowing the system controller or a remote control transmitter to individually address and control each emitter module. Electrical lines containing both power and communication lines connect the plurality of emitter modules with the system controller. Each emitter module stores a balance reference value and an ion output current reference value for use by automatic balance control and automatic ion output current control circuitry. These reference values are stored in a software-adjustable memory so that they may be easily changed via the system controller or via the remote control transmitter if actual measured balance or decay times in the work space, such as measured by a charged plate monitor, indicate an ion imbalance or out of range ion output current. Each emitter module can send detailed alarm condition information and emitter module identification information to the system controller upon detection of a malfunction. Each emitter module connected to the system controller may be individually set to a desired operating power mode. The emitter modules use a switching power supply to lessen effects of line loss. Each emitter module includes miswire protection circuitry so that the electrical lines may be automatically flipped if initially connected in the reverse manner. <IMAGE>
Patent JP-3802160-B2 (JP)
IPC: B65D85/38
Filed: 1996-09-27
Granted: 2006-07-26
Abstract: A packaging arrangement for the sealed containment of at least one hydrophilic contact lens in a sterile aqueous solution, comprising at least one injection molded or thermoformed plastic base member (10;40) having a cavity (20;42;52) for containing a contact lens immersed in said solution, said base member (10;40) including a planar flange (12) extending outwardly about the periphery of the outer edge of said cavity (20;42;52), said cavity (20;42;52) consisting of an indentation extending from the plane of the upper surface of said flange (12), and a depending wall (48) projecting downwardly from a bottom surfact of said flange (12) closely inwardly of the peripheral edges (14,16) of said flange (12) and extending about at least portions of the periphery of said flange (12); characterised in that the upper surface (24) of said flange (12) has a raised surface area (22) extending about said cavity (20;42;52) for facing a superimposed cover sheet (36) in contacting relationship. <IMAGE>
Patent JP-2592870-B2 (JP)
IPC: C07J73/00
Filed: 1987-11-20
Granted: 1997-03-19
Abstract: The compounds of formula (I) <CHEM> wherein R is selected from hydrogen, methyl or ethyl, and R<1> is C1-12 straight or branched chain alkyl wherein one of the hydrogens is substituted by hydroxy, carboxylic acid or C1-4 alkyl ester, and A is -CH2-CH2 or -CH=CH-, and pharmaceutical formulations of the above compounds are active as testosterone 5 alpha -reductase inhibitors and thus are useful for treatment of acne, seborrhea, female hirsutism or benign prostatic hypertrophy.
Patent JP-H0433280-B2 (JP)
IPC: B42F13/14
Filed: 1986-12-26
Abstract: A binding device is disclosed, which comprises an elongated fixture (10) having at least one pipe (12) fitting in the vicinity of one longitudinal side end thereof and a cover plate (14) having in the vicinity of its longitudinal one end at least one coupling rod (16) adapted to be inserted into said pipe (12) fitting, wherein the fixture (10) is provided with support members (18) along its longitudinal opposite side end at a predetermined distance, each of said support members (18) being provided with a vertically extended slit (20) and an external recess (22) in commnunication with the slit (20) and the fixture (10) is further provided with elastic arm members (24) at its opposite cross ends, each of said elastic arm members (24) at its one end being secured to the fixture (10) and at its opposite free end being confronted with the recess (22) of the support member (18), while the cover plate (14) is provided in the vicinity of its longitudinal opposite end with insertion members (26) each comprising a vertical guide piece member (28) and a flexible piece member (34) with an outward protrusion and arranged symmetrically to cope with the support members (13) of the fixture (10).
Patent JP-3658160-B2 (JP)
IPC: H01L31/048
Filed: 1997-11-17
Granted: 2005-06-08
Abstract: In a moldless semiconductor device comprising a semiconductor chip held between two outer-connecting terminals and connected electrically to the terminals, at least one terminal of the two terminals has, at its region contiguous to the semiconductor chip or at its region contiguous to the semiconductor chip and a region vicinal thereto, a hardness made different from the hardness of the other region. This moldless semiconductor device can be well tough to external force and also can provide a moldless semiconductor device having a high reliability when used in photovoltaic device modules. <IMAGE>
Patent JP-3512098-B2 (JP)
IPC: H04N5/783
Filed: 1996-12-13
Granted: 2004-03-29
Abstract: A recording apparatus configured to receive analog video and audio signals, digitize and compress the same, and record the compressed audio and video signals on a digital recording medium such as an optical disk. As the audio and video signals are received and recorded, time segments of the audio signals are analyzed for certain features such as whether the time segment corresponds to instrumental music, vocal music or conversational speech. A table of contents is then generated corresponding to the feature analysis and digitally stored on the storage medium. As a result, the recorded audio is characterized over time, e.g., on a frame by frame basis. A high degree of versatility is thereby provided in the playback process, such as the ability to skip portions having certain audio types or to quickly scroll to desired portions of the recorded audio programs. Reproducing apparatuses enable the user to selectively reproduce segments of the recorded audio and video. <IMAGE>
Patent JP-3870583-B2 (JP)
IPC: G10L13/06
Filed: 1998-12-09
Granted: 2007-01-17
Abstract: PROBLEM TO BE SOLVED: To obtain a speech synthesizer by which the interval between a VCV (a continued unit of vowel to consonant to vowel) and a morpheme is heard naturally without being interrupted in the case of synthesizing the VCV and the morpheme. SOLUTION: The 'bango' stored in a morpheme database 13d is started from the vowel normal part of the vowel 'a' of a first syllable 'ba' and is completed with the vowel normal part 'o:' of the last syllable 'go:' and a silence Q is not present at the head and the rear. Consequently, when the morpheme 'bango' is synthesized to the VCV 'denwaba' stored in a VCV data base 13c, they become 'denwagango:', since a silence Q is not exit in a synthetic part, a natural synthetic voice can be outputted.
Patent JP-H0744447-B2 (JP)
IPC: H03K5/13
Filed: 1984-12-31
Abstract: An improved multiple frequency digital phase-locked loop circuit 10 is described. The improved digital phase-locked loops utilizes a single circuit 12 to effect both phase and frequency adjustments. The multiple frequency digital phase-locked loop effects phase adjustments by selectively combining or subtracting a reference clock signal 30 with a derived programmable clock signal thereby generating a composite digital phase-locked loop clock signal. The multiple frequency provides frequency adjustments by selectively adding or subtracting pulses from the composite clock signal at a rate determined by a programmably controllable clock signal. The improved multifrequency digital phase-locked loop is suitable for use as a tone detector with the addition of a lock detector 22 wherein the phase-locked loop can be programmed for a plurality of known operating frequencies. <IMAGE>
Patent JP-3168005-B2 (JP)
IPC: A61P3/08
Filed: 1992-01-14
Granted: 2001-05-21
Abstract: Non-depleting CD4 monoclonal antibodies may be used in the treatment of insulin-dependent diabetes mellitus.
Patent JP-2547714-B2 (JP)
Inventor: TULLIS RICHARD H
IPC: F02C6/12
Filed: 1982-10-08
Granted: 1996-10-23
Abstract: For use in controlling biologic functions in an organism, a stabilized oligonucleotide, preferably in a phosphotriester form, having a base sequence substantially complementary to a portion of messenger ribonucleic acid coding for a biological component, such as a protein, of the organism. The oligonucleotide has about fourteen bases or more, such as twenty-three bases, and can be a deoxyribo-nucleotide. The oligonucleotide sequence can be derived from the organism's ribonucleic or deoxyribonucleic acid that codes for a vital protein, and can be synthesized in bulk either chemically or by insertion into a plasmid.
Patent JP-3364684-B2 (JP)
IPC: F27B15/02
Filed: 1991-08-22
Granted: 2003-01-08
Abstract: This invention relates to an apparatus, method and product wherein fine particles of fly ash containing carbon are oxidized in a dry, bubbling fluid bed of previously introduced fine particles of the same fly ash so that the subsequently removed particles have reduced carbon content and are useful as pozzolan, suitable for use, without further processing, to replace a portion of the cement in concrete. The preferred conditions are a temperature of about 1300 DEG  to 1800 DEG  F., air velocity of between at least about 0.5, but not more than about 3 ft./sec., residence time of at least about 2 minutes but up to 100 minutes, volume ratio of air to fly ash of between about 1,000 and 1500, and an excess of oxygen between about 5% and 15%.
Patent JP-3221878-B2 (JP)
IPC: G05B19/042
Filed: 1991-12-09
Granted: 2001-10-22
Abstract: A control for an injection molding machine is provided including: a processor module producing set point signals in response to detection of coincidence of, selectably, analogue input signals, binary status signals, and elapsed time signals; and, a signal processing module for periodically producing control signals in response to the set point signals, measured parameter signals and control algorithms relating set point values and measured parameter values. A DC output interface module is provided including a plurality of DC output interface circuits for applying binary control signals to machine devices. The DC output interface circuits include self-latching over-current protection including means for sensing a latched condition thereof to produce an over-current fault indicating signal available to the processor module. The processor module includes an expansion bus for connection of the signal processing module and the DC output interface module.
Patent JP-2528218-B2 (JP)
IPC: A61P9/10
Filed: 1990-04-19
Granted: 1996-08-28
Abstract: This invention concerns novel aminopyrimidinium salts of the formula I:  <IMAGE>  in which R1 is alkyl, alkenyl, cycloalkyl, phenyl, phenylalkyl or cycloalkyl-alkyl; one of R2 and R6 is a basic group selected from amino, alkylamino, dialkylamino of up to eight carbon atoms, pyrrolidino, piperidino and morpholino; and the other of R2 and R6 is hydrogen, alkyl, alkenyl, alkoxyalkyl, phenyl, phenylalkyl, cycloalkyl or cycloalkyl-alkyl; or both of R2 and R6 are basic groups as mentioned above; and R5 is hydrogen, (1-4C)alkyl or (3-6C)alkenyl; or R2 is a basic group as mentioned above, and R5 and R6 together form alkylene or, together with the appendant carbon atoms of the pyrimidine ring, complete a benzene ring; R4 is hydrogen, alkyl, cycloalkyl-alkyl, alkenyl, alkynyl or phenylalkyl; or R4 is an optionally substitutued alkylene or alkenylene linked to the nitrogen atom of the group Q.A.N-, either of which linking groups may thereby completing a ring including two adjacent carbon atoms of Q, the carbon atoms of A and the adjacent nitrogen atom of the group -A.N-; A is a direct bond to the the group -N(R4)- or is alkylene or oxyalkylene; Q is a pyridyl, furyl, thienyl or phenyl moiety; and Y is a physiologically acceptable anion; but excluding a number of compounds specified hereinafter. The invention also includes certain closely related anhydro-base derivatives which, like the formula I compounds, possess beneficial effects on the cardiovascular system (and in particular beneficial effects modulated via the sino-atrial node). Also included are pharmaceutical compositions containing the formula I compound (or a related anhydro-base) as active ingredient, and processes for the manufacture of the various novel compounds.
Patent JP-3347328-B2 (JP)
IPC: C08L23/12
Filed: 1993-10-07
Granted: 2002-11-20
Abstract: A polymeric composition particularly suitable for obtaining heat sealable soft polypropylene fibers comprises a propylene homopolymer modified with a propylene homopolymer having an isotacticity index higher than 80, an ethylene-propylene copolymer insoluble in xylene at 23 DEG  C. and a propylene copolymer soluble in xylene at 23 DEG  C.
Patent JP-3367665-B2 (JP)
IPC: G07D5/08
Filed: 1991-07-04
Granted: 2003-01-14
Abstract: PCT No. PCT/AU91/00295 Sec. 371 Date Feb. 22, 1993 Sec. 102(e) Date Feb. 22, 1993 PCT Filed Jul. 4, 1991 PCT Pub. No. WO92/01270 PCT Pub. Date Jan. 23, 1992.A coin validator (10) has a coin path (26) which passes between one set of detect coils (40, 42). The set of coils (40, 42) is connected in a detect circuit, and the coils (40, 42) are adapted to be energized with a single pulse. The decay curve (70) of the voltage in the coils (40, 42) is processed to produce a set of three numbers of clock counts defining each coin, which are stored in a microprocessor. Preprogramming of the validator (10) involves generating sets of numbers for representatives of a coin type to create three ranges of numbers, within which respective range a subsequent coin's set of numbers must fall in order for it to be defined as an example of the coin type. The coin path (26) is arranged at an angle to the vertical, and the base (32) is arranged at an angle to the horizontal such that the angle between one wall (36) and the base (32) is between 90 DEG  and 180 DEG , causing coins passing along the coin path (26) to orient themselves such that each of them has point contact on the base (32) and on one wall (36), thereby occupying a generally similar position with respect to the coils (40, 42).
Patent JP-3477210-B2 (JP)
IPC: D03D15/56
Filed: 1997-09-12
Granted: 2003-12-10
Abstract: The present invention is directed towards yarns of covered high modulus filament materials and fabrics which are formed therefrom. The present invention is intended to provide a composite filamentary material which exhibits the advantages of high modulus materials while providing a means for compensating the diminished properties exhibited by such fibers in the direction normal to molecular chain orientation. The composite filament structure of the present invention is a high modulus filament material covered with bicomponent filaments. The composite filament structure has a first interior layer of high modulus filament material and a second exterior layer of bicomponent fibers, the second exterior layer of bicomponent fibers being covered around the first interior layer of high modulus material along its entire length. The entire surface area of the high modulus material should be covered.
Patent JP-3273785-B2 (JP)
IPC: A61K47/12
Filed: 1991-08-12
Granted: 2002-04-15
Abstract: A composition is disclosed containing non-esterified fatty acids having 14-18 carbon atoms, monoglycerides which are monoesters of glycerol and fatty acids having 14-18 carbon atoms, lysophosphatidylcholine in which the fatty acid moiety has 14-18 carbon atoms and bicarbonate. The compositions can optionally also contain bile salts. These compositions form submicron size colloidal particles and can act as vehicles for transporting orally administered drugs, sources of calories in the form of readily absorbable fats and as particles for topical application to the skin. A method of making these particles is also described.
Patent JP-2947613-B2 (JP)
IPC: H05B3/14
Filed: 1995-01-11
Granted: 1999-09-13
Abstract: PCT No. PCT/EP95/00076 Sec. 371 Date Jul. 12, 1996 Sec. 102(e) Date Jul. 12, 1996 PCT Filed Jan. 11, 1995 PCT Pub. No. WO95/19626 PCT Pub. Date Jul. 20, 1995A heat-sensitive resistive compound is formed by a mixture of particles of at least one electrically conducting material (A) in the solid state and of at least one resin (B) in the solid state; the mixture is dispersed in at least one liquid solvent (C); the percentage by weight of the electrically conducting material (A) with respect to the total weight of the anhydrous compound is 5% to 70%. The resistance of the compound after a furnace process increases, as the temperatures rises, in a substantially linear manner for temperatures that are approximately lower than or equal to 70 DEG  C. and in a substantially exponential manner for temperatures that are approximately higher than 70 DEG  C. The relative increase in the resistance of the compound with respect to its resistance at ambient temperature is at least 3 for temperatures higher than 100 DEG  C. and at least 5 for temperatures above 115 DEG  C. The method for providing a PTC device includes the deposition, by printing or screen-printing, of the resistive compound on a flexible or rigid laminar support made of insulating material (2) along an electric path (3) that connects conducting paths (6) which form electrodes; the compound is deposited when cold and is subjected to one or more furnace processes at a temperature that is at least equal to 110 DEG  C. for a period and a number of times that are sufficient to achieve the complete evaporation of the solvent (C) and the adhesion of the resin (B) to the substrate.
Patent JP-3558643-B2 (JP)
IPC: G01N33/577
Filed: 1996-01-19
Granted: 2004-08-25
Abstract: The present invention relates to a ultrasensitive process for assaying cardiac troponine I by means of chemiluminescence.
Patent JP-3865077-B2 (JP)
IPC: A61K9/70
Filed: 1995-04-15
Granted: 2007-01-10
Abstract: A collagen preparation for the controlled release of active substances is characterized in that it has mixtures of acid-insoluble collagens with different molecular weight distributions.
Patent JP-3580825-B2 (JP)
IPC: C12P41/00
Filed: 1996-06-17
Granted: 2004-10-27
Abstract: PCT No. PCT/GB96/01422 Sec. 371 Date Dec. 23, 1997 Sec. 102(e) Date Dec. 23, 1997 PCT Filed Jun. 17, 1996 PCT Pub. No. WO97/00968 PCT Pub. Date Jan. 9, 1997A compound of formula (III) is produced by selectively reducing a compound of formula (II) using a reductase possessing the properties of one produced by Beauveria, Candida, Kluyveromyces, Torulaspora or Pichia. or A compound of formula is produced by selectively reducing a compound of formula II using a reductase possessing the properties of one produced by Candida pelliculosa, Neurospora crassa, Pichia trehalophila or preferably Hansenula anomola.
Patent JP-3749261-B2 (JP)
IPC: A61B18/08
Filed: 1996-04-24
Granted: 2006-02-22
Abstract: An apparatus, and method for endometrial ablation by heating an inflation medium within a distensible bladder positioned within a uterus of a patient. The apparatus comprises an elongate tubular member, a handle, a distensible bladder and a heating element disposed within said distensible bladder. The system includes a controller configured for providing and regulating electric current to the heating element. The controller also includes a pressure sensor for regulating the pressure in the distensible bladder. Pressure and temperature displays and other operator controls are located on the controller unit. The method for performing endothelial ablation comprises inserting the distensible bladder and a portion of the tubular member into a uterus of a patient. The inflation medium within the distensible bladder is heated by providing electric current to the resistive wire of the heating element. The inflation medium within the distensible bladder is heated to a desired temperature and temperature and pressure within the distensible bladder are maintained for a desired time interval. The distensible bladder is then deflated and removed from the uterus.